These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26871475)

  • 21. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation.
    Su F; Bradley WD; Wang Q; Yang H; Xu L; Higgins B; Kolinsky K; Packman K; Kim MJ; Trunzer K; Lee RJ; Schostack K; Carter J; Albert T; Germer S; Rosinski J; Martin M; Simcox ME; Lestini B; Heimbrook D; Bollag G
    Cancer Res; 2012 Feb; 72(4):969-78. PubMed ID: 22205714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
    Deng S; Zhang C; Yang L; Ma L
    Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
    Kaushik G; Kwatra D; Subramaniam D; Jensen RA; Anant S; Mammen JM
    Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.
    Sinnberg T; Makino E; Krueger MA; Velic A; Macek B; Rothbauer U; Groll N; Pötz O; Czemmel S; Niessner H; Meier F; Ikenberg K; Garbe C; Schittek B
    EBioMedicine; 2016 Jun; 8():132-149. PubMed ID: 27428425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis.
    Han HK; Van Anh LT
    Anticancer Res; 2012 Oct; 32(10):4445-52. PubMed ID: 23060571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Honokiol produces anti-neoplastic effects on melanoma cells in vitro.
    Mannal PW; Schneider J; Tangada A; McDonald D; McFadden DW
    J Surg Oncol; 2011 Sep; 104(3):260-4. PubMed ID: 21472732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
    Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
    Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.
    Prasad R; Kappes JC; Katiyar SK
    Oncotarget; 2016 Feb; 7(7):7899-912. PubMed ID: 26760964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
    Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin AR; Bonner M; Shin HJ; Chen ZG; Arbiser JL; Shin DM
    PLoS One; 2014; 9(2):e86369. PubMed ID: 24586249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Honokiol is a potent scavenger of superoxide and peroxyl radicals.
    Dikalov S; Losik T; Arbiser JL
    Biochem Pharmacol; 2008 Sep; 76(5):589-96. PubMed ID: 18640101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
    Yang H; Higgins B; Kolinsky K; Packman K; Bradley WD; Lee RJ; Schostack K; Simcox ME; Kopetz S; Heimbrook D; Lestini B; Bollag G; Su F
    Cancer Res; 2012 Feb; 72(3):779-89. PubMed ID: 22180495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
    Kumar A; Kumar Singh U; Chaudhary A
    Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
    Chen F; Wang T; Wu YF; Gu Y; Xu XL; Zheng S; Hu X
    World J Gastroenterol; 2004 Dec; 10(23):3459-63. PubMed ID: 15526365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction induced by honokiol.
    Dong JX; Zhao GY; Yu QL; Li R; Yuan L; Chen J; Liu Y
    J Membr Biol; 2013 May; 246(5):375-81. PubMed ID: 23595822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia increases the heterogeneity of melanoma cell populations and affects the response to vemurafenib.
    Pucciarelli D; Lengger N; Takáčová M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
    Mol Med Rep; 2016 Apr; 13(4):3281-8. PubMed ID: 26936534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol, a multifunctional tumor cell death inducer.
    Tian W; Xu D; Deng YC
    Pharmazie; 2012 Oct; 67(10):811-6. PubMed ID: 23136712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma Cells.
    Luo H; Umebayashi M; Doi K; Morisaki T; Shirasawa S; Tsunoda T
    Anticancer Res; 2016 Jul; 36(7):3585-9. PubMed ID: 27354627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honokiol inhibits hypoxia-inducible factor-1 pathway.
    Lan KL; Lan KH; Sheu ML; Chen MY; Shih YS; Hsu FC; Wang HM; Liu RS; Yen SH
    Int J Radiat Biol; 2011 Jun; 87(6):579-90. PubMed ID: 21473672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T; Katiyar SK
    Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.